SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Par Drugs & Chem. - Quaterly Results

15 Feb 2025 Evaluate
The sales is pegged at Rs. 213.81 millions for the December 2024 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 239.99 millions during the year-ago period.A big loss of -83.08% reported for the quarter ended December 2024 to Rs. 5.79  millions from Rs. 34.21 millions.Operating profit for the quarter ended December 2024 decreased to 17.01 millions as compared to 54.57 millions of corresponding quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 213.81 239.99 -10.91 786.44 728.21 8.00 956.40 957.49 -0.11
Other Income 2.72 2.29 18.78 13.62 2.90 369.66 2.42 2.38 1.68
PBIDT 17.01 54.57 -68.83 184.34 170.13 8.35 230.60 184.45 25.02
Interest 0.14 0.20 -30.00 0.63 0.63 0.00 1.07 1.33 -19.55
PBDT 16.87 54.37 -68.97 183.71 169.50 8.38 229.53 183.12 25.34
Depreciation 9.14 8.65 5.66 27.26 25.44 7.15 34.36 32.33 6.28
PBT 7.73 45.72 -83.09 156.45 144.06 8.60 195.17 150.79 29.43
TAX 1.94 11.51 -83.15 39.37 36.26 8.58 50.16 37.45 33.94
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.40 -0.50 -180.00
PAT 5.79 34.21 -83.08 117.08 107.80 8.61 145.01 113.34 27.94
Equity 123.05 123.05 0.00 123.05 123.05 0.00 123.05 123.05 0.00
PBIDTM(%) 7.96 22.74 -65.01 23.44 23.36 0.33 24.11 19.26 25.16
Peers
Company Name CMP
Sun Pharma Inds. 1834.40
Dr. Reddys Lab 1306.80
Cipla 1362.85
Zydus Lifesciences 940.10
Lupin 2459.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×